Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases

[1]  Ze-tian Shen,et al.  A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis , 2017, Medicine.

[2]  Jong-Hee Chang,et al.  Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study , 2017, Radiation oncology journal.

[3]  M. Buglione,et al.  Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique , 2016, Radiation Oncology.

[4]  David A. Larson,et al.  Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases , 2016, Oncotarget.

[5]  M. Tsao.  Brain metastases: advances over the decades. , 2015, Annals of palliative medicine.

[6]  M. Mehta.  The controversy surrounding the use of whole-brain radiotherapy in brain metastases patients. , 2015, Neuro-oncology.

[7]  H. Shirato,et al.  Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. , 2015, JAMA oncology.

[8]  J. Buckner,et al.  NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Mehta,et al.  Strategies for preservation of memory function in patients with brain metastases. , 2015, Chinese clinical oncology.

[10]  A. Padovani,et al.  The treatment of patients with 1–3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis , 2015, La radiologia medica.

[11]  J. Beyene,et al.  Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. , 2015, International journal of radiation oncology, biology, physics.

[12]  J. Bruce,et al.  Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience , 2015, Journal of Neuro-Oncology.

[13]  É. L. Rhun,et al.  Épidémiologie des lésions métastatiques cérébrales , 2015 .

[14]  S. Goel,et al.  Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries , 2015, South Asian Journal of Cancer.

[15]  Mohini Singh,et al.  Brain Metastasis-Initiating Cells: Survival of the Fittest , 2014, International journal of molecular sciences.

[16]  P. Brown,et al.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. , 2013, Neuro-oncology.

[17]  Susan M. Chang,et al.  Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. , 2013, The Lancet. Oncology.

[18]  Susan M. Chang,et al.  Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. , 2013, The Lancet. Oncology.

[19]  S. Senan,et al.  Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgery. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  A. Sahgal,et al.  A meta‐analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases , 2012, Cancer.

[21]  P. Wen,et al.  Epidemiology of Brain Metastases , 2012, Current Oncology Reports.

[22]  T. Ellis,et al.  The Role of Surgery, Radiosurgery and Whole Brain Radiation Therapy in the Management of Patients with Metastatic Brain Tumors , 2011, International journal of surgical oncology.

[23]  F. Caparrotti,et al.  Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life , 2011, Radiation oncology.

[24]  M. Mehta,et al.  Presentation, patterns of care, and survival in patients with brain metastases , 2011, Cancer.

[25]  L. Strigari,et al.  IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique , 2011, Journal of experimental & clinical cancer research : CR.

[26]  L. Collette,et al.  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Kelly,et al.  Neurocognitive function after WBRT plus SRS or SRS alone. , 2010, The Lancet. Oncology.

[28]  C. Combescure,et al.  Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study , 2010, Radiation oncology.

[29]  T. Ryken,et al.  The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[30]  D. Kondziolka,et al.  The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[31]  D. Kondziolka,et al.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[32]  P. Brown,et al.  Whole-brain radiotherapy in the management of brain metastasis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[34]  P. Kehrli,et al.  [Epidemiology of brain metastases]. , 1999, Neuro-Chirurgie.

[35]  L D Lunsford,et al.  Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. , 1999, International journal of radiation oncology, biology, physics.

[36]  P. Wen,et al.  Management of brain metastases. , 1999, Oncology.

[37]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[38]  A S Garden,et al.  Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. , 1995, International journal of radiation oncology, biology, physics.

[39]  P Chomy,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. , 1995, Journal of the National Cancer Institute.

[40]  D J Brenner,et al.  The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. , 1993, International journal of radiation oncology, biology, physics.

[41]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[42]  J. Nickson,et al.  Roentgen‐ray therapy of cerebral metastases , 1954, Cancer.

[43]  L. Collette,et al.  A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Hiroki Shirato,et al.  Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .

[45]  W. Curran,et al.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  C. Filley,et al.  Toxic leukoencephalopathy. , 2001, The New England journal of medicine.